Track McKesson Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

McKesson Corporation MCK Open McKesson Corporation in new tab

775.97 USD
P/E
19.80
EPS
38.41
Yield
0.42%
Safety Score
100
P/B
-42.02
Beta
0.36
Target Price
949.73 USD
McKesson Corporation logo

McKesson Corporation

🧾 Earnings Recap – Q4 2026

McKesson shares declined modestly by 1.0% following its fiscal Q4 2026 report, reflecting investor caution amid a muted outlook for fiscal 2027 despite stable operational execution and ongoing strategic progress.

  • Adjusted earnings per diluted share grew 18% in fiscal 2026, supported by growth across strategic platforms.
  • Operating cash flow reached $6.2 billion, surpassing internal plans, with $5.1 billion returned to shareholders.
  • Continued progress on Medical-Surgical Solutions separation, including transition service agreements and minority investor partnership with Apollo.
  • Fiscal 2027 EPS guidance range set at $43.80 to $44.60, lacking upward revision and suggesting limited near-term earnings acceleration.
  • Strategic initiatives such as oncology platform expansion and technology adoption continue, though offset by restrained margin commentary and cautious outlook.
📅
Loading chart...
Key Metrics
Earnings dateAug. 5, 2026
P/E19.80
EPS38.41
Book Value-18.10
Price to Book-42.02
% Insiders0.032%
Growth
Revenue Growth0.06%
Earnings Growth0.37%
Estimates
Forward P/E15.11
Forward EPS50.32
Target Mean Price949.73
Dividend
Dividend Yield0.42%
Annual dividends3.17 USD
Ex-Div. DateJune 1, 2026
Payout8.00%
5y avg Yield0.64%

DCF Valuation

Tweak assumptions to recompute fair value for McKesson Corporation (MCK)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

McKesson Corporation Logo McKesson Corporation Analysis (MCK)

United States Health Care Official Website Stock

Is McKesson Corporation a good investment? McKesson Corporation (MCK) is currently trading at 775.97 USD. Market analysts have a consensus price target of 949.73 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 19.80. This valuation is generally in line with the broader market.

Earnings Schedule: McKesson Corporation is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 50.32.

For income investors, McKesson Corporation pays a dividend yield of 0.42%. With a payout ratio of 8%, the dividend appears sustainable.

Investor FAQ

Does McKesson Corporation pay a dividend?

Yes, it pays an annual dividend of 3.17 USD (0.42% yield).

What asset class is McKesson Corporation?

McKesson Corporation is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of 38.41.

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Exchange Ticker
NYQ (United States) MCK
SAO (Brazil) M1CK34.SA
LSE (United Kingdom) 0JZU.L
FRA (Germany) MCK.F
MEX (Mexico) MCK.MX
Dividend Yield

0.42% (5y avg: 0.64%)

Annual Dividends

3.17 USD

Next ex. div date

June 1, 2026

Payout Ratio

8.00%

Historical Dividends
Year Total Dividends
2027 1.82 USD
2026 3.40 USD
2025 2.95 USD
2024 2.57 USD
2023 2.24 USD
2022 1.95 USD
2021 1.73 USD
2020 1.65 USD
2019 1.58 USD
2018 1.41 USD
2017 1.18 USD
2016 1.12 USD
2015 1.00 USD
2014 0.96 USD
2013 0.84 USD
2012 0.80 USD
2011 0.76 USD
2010 0.60 USD
2009 0.48 USD
2008 0.36 USD
2007 0.24 USD
2006 0.24 USD
2005 0.24 USD
2004 0.24 USD
2003 0.24 USD
2002 0.24 USD
2001 0.24 USD
2000 0.24 USD
1999 0.31 USD
1998 0.50 USD
1997 0.50 USD
1996 0.50 USD
1995 0.38 USD

Yearly aggregated dividends

Dividends

McKesson Corporation
Jul 01, 2026 Upcoming
Dividend
0.82 USD
McKesson Corporation
Apr 01, 2026 Paid
Dividend
0.82 USD
McKesson Corporation
Jan 02, 2026 Paid
Dividend
0.82 USD
McKesson Corporation
Oct 01, 2025 Paid
Dividend
0.82 USD
McKesson Corporation
Jul 01, 2025 Paid
Dividend
0.71 USD

Historical Split Corporate Actions

Split Date Split Ratio to 1
Jan. 5, 1998 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion